English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 15 December 2020, 09:00 HKT/SGT
Share:
    

Source: Azooka Labs
Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
Molecular Transport Medium at the price of VTM

BANGALORE, INDIA, Dec 15, 2020 - (ACN Newswire) - Azooka Labs, a leading safe fluorophore company with specialization in Molecular Biology products, reveals its first range of novel COVID-19 diagnostics products. RNA Wrapr is a molecular transport medium for COVID-19 sample collection, developed as part of the COVID-19 response team from Indian Institute of Science.


Molecular Transport Media that inactivates the Coronavirus immediately. Not only that! Azooka's RNA Wrapr does not require dry ice for storage and can be processed until a week. A storage medium for COVID-19 that is safe, easy to use and affordable. (RNA Wrapr comes in 3ml or 10ml vials with Fluccoluated Nylon Nasal Swabs. Price starts at INR 99 per vial.)


RNA Wrapr inactivates the virus immediately only preserving DNA/RNA content required for RT-PCR tests. The sample tubes can be stored up to 7 days in Room Temperature and transported without dry ice or gel packs. RNA Wrapr is safe to handle even during unexpected accidental spillage or handling errors. Developing countries can collect samples in centers without BSL2 or BSL3 certifications.

Azooka's RNA Wrapr is priced at INR 99 in India, aligned with the price of one litre of petrol, to help the diagnostic centers upgrade from VTM to MTM. Azooka plans to enter the APAC market through partners with $9 and $6 pricing plans per test.

"Azooka has actively been a part of the fight against COVID by developing PCR and RT PCR kits with support from Dept of Biotechnology and Elevate Karnataka even before the pandemic hit us," quoted Alex D Paul, CEO, Azooka Labs. He further added, "MTM has ensured safety and security of COVID-19 samples to be stored at Room Temperature for up to seven days".

"Azooka is the only startup from India working to replace Carcinogenic and Mutagenic SYBR dyes widely used in RUO and Diagnostics reagents. Safety and cost savings needed for COVID crisis management today are the highlights of Azooka's MTM," says Dr. C V Natraj, former SVP, Corporate Research, Unilever plc.

"Azooka is striving to provide a safer molecular grade transport medium that is at sub Rs. 100. We are appealing to a segment of users, who care about the safety of their frontline health care workers," stated Dr. Fatima Benazir, Co-founder & CSO, Azooka Labs.

About Azooka Labs
Azooka is a patented fluorophore company focused on developing safe biotech consumables at a price affordable for all countries across the globe. Azooka's first diagnostics product RNA Wrapr- molecular transport medium, is approved by ICMR and certified by CE. Azooka is an IISc invested startup based in Bengaluru with R&D unit at the Indian Institute of Science and manufacturing facility in Peenya Industrial Area, Karnataka.

Azooka was recently awarded the 'Best Women-Led Enterprise' at StartUp India 2020. Azooka is open for licensing and partnerships worldwide. Governments and Health Organizations can directly contact Azooka for COVID-19 Crisis Management. For more information visit: http://azooka.life/ and for the prices visit: https://azooka.life/rna-wrapr-molecular-transport-medium/

Media Contact:
Alex D Paul, CEO
+91-9108424562
[email protected]


Topic: Press release summary
Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Edvantage Group (0382.HK) Announced Fourth Consecutive Positive Profit Alert Since Listing  
Mar 8, 2021 13:20 HKT/SGT
Hitachi Joins 'The Valuable 500', an International Initiative to Promote Disability Inclusion  
Mar 8, 2021 11:28 HKT/SGT
UNISOC and Ericsson Complete 5G NR 700MHz DL 4x4 MIMO Tests  
Mar 8, 2021 10:00 HKT/SGT
No. 1 in Fujian! RMB 880 Million of Import and Export of Agricultural and Fishery Products at Pingtan Port in 2020  
Mar 8, 2021 10:00 HKT/SGT
GBA Healthcare Working Group Releases White Paper as First Asset in Blockchain Ethical Design Framework for Healthcare  
Mar 8, 2021 07:27 HKT/SGT
UREEQA Welcomes Dean Drever, a Sculptor Who Has Produced Multi-Million Dollar Works of Art  
Mar 8, 2021 06:00 HKT/SGT
Tianyun International: Rainbow Lead Ventures Limited Becomes a New Strategic Shareholder of the Group  
Mar 6, 2021 14:10 HKT/SGT
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease  
Mar 5, 2021 16:51 HKT/SGT
CUPNOODLES MUSEUM HONG KONG BY NISSIN FOODS SET FOR LAUNCH   
Mar 5, 2021 12:53 HKT/SGT
Moonstake Partners with P2P Escrow Service Escaroo  
Mar 5, 2021 12:30 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575